525 related articles for article (PubMed ID: 28374966)
1. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
[TBL] [Abstract][Full Text] [Related]
2. 5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.
Yasuda M; Kato S; Yamanaka N; Iimori M; Matsumoto K; Utsumi D; Kitahara Y; Amagase K; Horie S; Takeuchi K
Br J Pharmacol; 2013 Mar; 168(6):1388-400. PubMed ID: 23072534
[TBL] [Abstract][Full Text] [Related]
3. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
[TBL] [Abstract][Full Text] [Related]
4. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
[TBL] [Abstract][Full Text] [Related]
5. Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis.
Li HL; Lu L; Wang XS; Qin LY; Wang P; Qiu SP; Wu H; Huang F; Zhang BB; Shi HL; Wu XJ
Front Cell Infect Microbiol; 2017; 7():455. PubMed ID: 29124041
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
[TBL] [Abstract][Full Text] [Related]
7. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats.
Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J
Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511
[TBL] [Abstract][Full Text] [Related]
8. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.
Kato S; Hayashi S; Kitahara Y; Nagasawa K; Aono H; Shibata J; Utsumi D; Amagase K; Kadowaki M
PLoS One; 2015; 10(1):e0116213. PubMed ID: 25565296
[TBL] [Abstract][Full Text] [Related]
9. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
[TBL] [Abstract][Full Text] [Related]
10. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
[TBL] [Abstract][Full Text] [Related]
12. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents.
Atiq A; Shal B; Naveed M; Khan A; Ali J; Zeeshan S; Al-Sharari SD; Kim YS; Khan S
Eur J Pharmacol; 2019 Jan; 843():292-306. PubMed ID: 30529194
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
[TBL] [Abstract][Full Text] [Related]
14. Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice.
Araújo CV; Lazzarotto CR; Aquino CC; Figueiredo IL; Costa TB; Alves LA; Ribeiro RA; Bertolini LR; Lima AA; Brito GA; Oriá RB
Braz J Med Biol Res; 2015 Jun; 48(6):493-501. PubMed ID: 25945744
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.
Azevedo OG; Oliveira RA; Oliveira BC; Zaja-Milatovic S; Araújo CV; Wong DV; Costa TB; Lucena HB; Lima RC; Ribeiro RA; Warren CA; Lima AÂ; Vitek MP; Guerrant RL; Oriá RB
BMC Gastroenterol; 2012 Jul; 12():35. PubMed ID: 22524518
[TBL] [Abstract][Full Text] [Related]
16. Protective role of casuarinin from Melastoma malabathricum against a mouse model of 5-fluorouracil-induced intestinal mucositis: Impact on inflammation and gut microbiota dysbiosis.
Chen KJ; Huang YL; Kuo LM; Chen YT; Hung CF; Hsieh PW
Phytomedicine; 2022 Jul; 101():154092. PubMed ID: 35430483
[TBL] [Abstract][Full Text] [Related]
17. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil elastase inhibitor (MPH-966) improves intestinal mucosal damage and gut microbiota in a mouse model of 5-fluorouracil-induced intestinal mucositis.
Chen KJ; Chen YL; Ueng SH; Hwang TL; Kuo LM; Hsieh PW
Biomed Pharmacother; 2021 Feb; 134():111152. PubMed ID: 33373916
[TBL] [Abstract][Full Text] [Related]
20. Lafutidine, a histamine H2 receptor antagonist with mucosal protective properties, attenuates 5-fluorouracil-induced intestinal mucositis in mice through activation of extrinsic primary afferent neurons.
Sano T; Utsumi D; Amagase K; Matsumoto K; Tominaga M; Higuchi K; Takeuchi T; Kato S
J Physiol Pharmacol; 2017 Feb; 68(1):79-90. PubMed ID: 28456772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
